USFDA Issues Warning Letter to Eugia Pharma for Manufacturing Lapses
August 25, 2024 13:25
USFDA has issued a warning letter to Eugia Pharma, a subsidiary of Aurobindo Pharma, for manufacturing lapses at its Hyderabad plant, citing data accuracy and process simulation issues.